Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

1.89
Delayed Data
As of Oct 17
 +0.06 / +3.28%
Today’s Change
1.65
Today|||52-Week Range
5.70
+8.62%
Year-to-Date
No recent news for Orexigen Therapeutics Inc.

Today’s Trading

Previous close1.83
Today’s open1.90
Day’s range1.80 - 1.95
Volume247,322
Average volume (3 months)128,761
Market cap$28.2M
Dividend yield--
Data as of 4:00pm ET, 10/17/2017

Growth & Valuation

Earnings growth (last year)+67.69%
Earnings growth (this year)-457.44%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+37.82%
P/E ratioNM
Price/Sales0.75
Price/Book0.47

Competitors

 Today’s
change
Today’s
% change
NTRPNeurotrope Inc-0.19-3.79%
PPHMPPeregrine Pharmaceut...+0.56+2.42%
PULMPulmatrix Inc-0.08-3.86%
PRPHProPhase Labs Inc0.000.00%
Data as of 3:59pm ET, 10/17/2017

Financials

Next reporting dateNovember 3, 2017
EPS forecast (this quarter)-$2.13
Annual revenue (last year)$33.7M
Annual profit (last year)-$24.5M
Net profit margin-72.75%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
Chief Operating Officer &
Executive Vice President
Thomas R. Cannell
Corporate headquarters
La Jolla, California

Forecasts